Data / Research funding / North Carolina / Zymeron Corporation
Zymeron Corporation: 9 NIH awards ($3.7M), fiscal years 2021 to 2026
Zymeron Corporation in Durham, NC is funded under 9 NIH awards ($3.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- NIH institution profile
- 10042923
- State
- North Carolina
- Note
- NIH gives no UEI for this institution, so NSF awards are not matched.
Awards
9 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| RAPID POINT OF CARE TESTS FOR TUBERCULOSIS | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,500,000 | August 12, 2021 | August 8, 2024 | ZHOU, YAN | reporter.nih.gov |
| One Test, One Kit for Identifying Active Hepatitis C Virus (HCV) Infection at Home | NIH | National Cancer Institute | 2022 | $400,000 | September 19, 2022 | September 18, 2023 | ZHOU, JASON | reporter.nih.gov |
| Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | July 1, 2021 | June 30, 2022 | LI, XU | reporter.nih.gov |
| Small Molecule Degraders of Intracellular HIV Proteins as Novel Anti-HIV Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | July 1, 2021 | June 30, 2022 | LIU, FANG | reporter.nih.gov |
| RAPID POINT OF CARE TESTS FOR HEPATITIS C VIRUS | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | August 31, 2021 | August 30, 2022 | ZHOU, JASON | reporter.nih.gov |
| DEVELOPMENT OF PEDIATRIC TUBERCULOSIS TREATMENT | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | September 3, 2021 | LIU, ZHIGANG | reporter.nih.gov | |
| POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT PATHOGENS | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $300,000 | July 1, 2022 | June 30, 2023 | ZHOU, JASON | reporter.nih.gov |
| Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $299,988 | July 1, 2021 | June 30, 2022 | ZHOU, JASON | reporter.nih.gov |
| Rapid Point of Care Test to Screen Human Papillomavirus in Low-Resource Settings | NIH | National Cancer Institute | 2023 | $13,720 | August 7, 2023 | August 6, 2024 | LI, QIAN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2023 | 1 | $13,720 | 0 | $0 |
| 2022 | 2 | $700,000 | 0 | $0 |
| 2021 | 6 | $2,999,988 | 0 | $0 |
Topics of its NIH awards
- Infectious Diseases
- Emerging Infectious Diseases
- HIV/AIDS
- Prevention
- Clinical Research
- Biodefense
- Behavioral and Social Science
- Bioengineering
- Chronic Liver Disease and Cirrhosis
- Digestive Diseases
- Hepatitis
- Hepatitis - C
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.